Guangzhou Baiyunshan Pharma (0874)

Currency in HKD
18.30
+0.11(+0.60%)
Closed·
0874 Scorecard
Full Analysis
Has raised its dividend for 7 consecutive years
High dividend Yield
0874 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.0918.30
52 wk Range
15.7624.00
Key Statistics
Bid/Ask
18.29 / 18.30
Prev. Close
18.19
Open
18.14
Day's Range
18.09-18.3
52 wk Range
15.76-24
Volume
1.23M
Average Volume (3m)
1.59M
1-Year Change
-6.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0874 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.26
Upside
+5.24%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Guangzhou Baiyunshan Pharma Company Profile

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company has operations in the People’s Republic of China and internationally. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Employees
28138
Market
Hong Kong

Compare 0874 to Peers and Sector

Metrics to compare
0874
Peers
Sector
Relationship
P/E Ratio
15.3x14.6x−0.5x
PEG Ratio
−0.45−0.420.00
Price/Book
1.1x0.9x2.6x
Price / LTM Sales
0.6x0.4x3.3x
Upside (Analyst Target)
18.3%11.4%40.6%
Fair Value Upside
Unlock20.8%5.3%Unlock

Analyst Ratings

2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 19.26
(+5.24% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.66%
Dividend Yield
4.83%
Industry Median 2.37%
Annualised payout
0.88
Paid unevenly
5-Years Growth
+6.32%
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
1.12 / 0.55
Revenue / Forecast
22.47B / --
EPS Revisions
Last 90 days

0874 Income Statement

FAQ

What Stock Exchange Does Guangzhou Baiyunshan Pharma Trade On?

Guangzhou Baiyunshan Pharma is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Guangzhou Baiyunshan Pharma?

The stock symbol for Guangzhou Baiyunshan Pharma is "0874."

What Is the Guangzhou Baiyunshan Pharma Market Cap?

As of today, Guangzhou Baiyunshan Pharma market cap is 47.43B.

What Is Guangzhou Baiyunshan Pharma's Earnings Per Share (TTM)?

The Guangzhou Baiyunshan Pharma EPS (TTM) is 1.66.

When Is the Next Guangzhou Baiyunshan Pharma Earnings Date?

Guangzhou Baiyunshan Pharma will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is 0874 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Guangzhou Baiyunshan Pharma Stock Split?

Guangzhou Baiyunshan Pharma has split 0 times.

How Many Employees Does Guangzhou Baiyunshan Pharma Have?

Guangzhou Baiyunshan Pharma has 28138 employees.

What is the current trading status of Guangzhou Baiyunshan Pharma (0874)?

As of 15 Aug 2025, Guangzhou Baiyunshan Pharma (0874) is trading at a price of 18.30, with a previous close of 18.19. The stock has fluctuated within a day range of 18.09 to 18.30, while its 52-week range spans from 15.76 to 24.00.

What Is Guangzhou Baiyunshan Pharma (0874) Price Target According to Analysts?

The average 12-month price target for Guangzhou Baiyunshan Pharma is HKD19.25978675, with a high estimate of HKD23.46425851 and a low estimate of HKD12.91589599. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +5.24% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.